Labeler · US market

Vensun Pharmaceuticals, Inc.

Vensun Pharmaceuticals, Inc. is a US drug labeler with US FDA registrations covering 4 drug concepts (4 currently active) across 26 packages.

ACTIVE — US

openFDA · updated weekly

Labeler codes42543

Active drugs4

Registrations7 active / 7

Packages26

Sole supplier of0 drugs

Portfolio4 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Fluoxetine Hydrochloride capsule	rx	3	11	SUPPLYING
Clopidogrel tablet	rx	2	9	SUPPLYING
Carisoprodol tablet	rx	1	3	SUPPLYING
Levocetirizine Dihydrochloride tablet	rx	1	3	SUPPLYING

At a glance

TypeLabeler
Labeler codes42543
Filing names1
Drugs (active)4
Drugs (all time)4
US registrations7
Packages26

Recent events

Shortages, recalls, and registration changes across all filing names.

Jul 18, 2018
RECALLRecall (Class II): Potassium Citrate Extended-Release Tablets, USP, 15 mEq, 100-count bottles, Rx only, Manufactured for: Vensun Pharmaceu…
Jul 18, 2018
RECALLRecall (Class II): Potassium Citrate Extended-Release Tablets, USP, 10 mEq, 100-count bottles, Rx only, Manufactured for: Vensun Pharmaceu…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.